Lyrixo Pharma Private Limited

Lyrixo Pharma Private Limited - healthcare in Pune, Maharashtra, India. Directors, charges & compliance details.
CIN U85190PN2022PTC210403 Incorporated 15 April 2022 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company healthcare
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
6
As per MCA filings
Company status
Active
MCA master data
Registrar
Pune
ROC office
Incorporated
15 Apr 2022
Date of incorporation
Entity type
Private Limited
As registered with MCA

About Lyrixo Pharma Private Limited

Data last updated:

Lyrixo Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 15 April 2022.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85190PN2022PTC210403.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sagar Abasaheb Kale and Shivprasad Subhash Patil.

The registered office is at Sno 167/168 Edenn Tower Pune – Bom Highway Rh No. 36, Maharashtra, India – 411027.

Company Details of Lyrixo Pharma Private Limited
CIN U85190PN2022PTC210403
Registration Number 210403
Incorporation Date 15 April 2022
ROC Pune
Listing Status Unlisted
Company Status Active
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Sno 167/168 Edenn Tower Pune – Bom Highway Rh No. 36, Maharashtra, India – 411027
  • Industry
    Healthcare, Human Health Activities, Other Human Health Activities
Comprehensive company report
Lyrixo Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Lyrixo Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Lyrixo Pharma Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Financials of Lyrixo Pharma Private Limited

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Lyrixo Pharma Private Limited

Lyrixo Pharma has 6 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rahul KhoseAdditional Director06 Jun 20224 Years 4 MonthsCurrent
Ketan Vijay WaghAdditional Director06 Jun 20224 Years 4 MonthsCurrent
Nitin Vasantrao PawarAdditional Director06 Jun 20224 Years 4 MonthsCurrent
Sagar Abasaheb KaleDirector15 Apr 20224 Years 5 MonthsCurrent
Shivprasad Subhash PatilDirector15 Apr 20224 Years 5 MonthsCurrent
Sumit Abasaheb KaleDirector15 Apr 20224 Years 5 MonthsCurrent

Charges & Borrowings of Lyrixo Pharma Private Limited

Lyrixo Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Lyrixo Pharma Private Limited

Employment history and EPFO contributions of people linked to Lyrixo Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Lyrixo Pharma Private Limited

Lyrixo Pharma Private Limited has 6 board changes on record since 2022: 6 appointments. The latest: Ketan Vijay Wagh was appointed as Additional Director on 06 Jun 2022.

Appointed
Ketan Vijay Wagh was appointed as Additional Director.
Appointed
Nitin Vasantrao Pawar was appointed as Additional Director.
Appointed
Rahul Khose was appointed as Additional Director.
Appointed
Sagar Abasaheb Kale was appointed as Director.
Appointed
Shivprasad Subhash Patil was appointed as Director.
Appointed
Sumit Abasaheb Kale was appointed as Director.
Incorporation
15 Apr 2022
Lyrixo Pharma Private Limited was registered on 15 Apr 2022 with Roc Pune & aged 4 years 5 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Lyrixo Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lyrixo Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Lyrixo Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Lyrixo Pharma Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lyrixo Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lyrixo Pharma Private Limited

Lyrixo Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in human health activities, within the healthcare industry. It was incorporated on 15 April 2022 (4+ years old) and is registered under CIN U85190PN2022PTC210403.

Lyrixo Pharma has 6 current directors:

The CIN (Corporate Identification Number) of Lyrixo Pharma is U85190PN2022PTC210403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lyrixo Pharma was incorporated on 15 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.

Ketan Vijay Wagh was appointed as Additional Director on 06 Jun 2022. Nitin Vasantrao Pawar was appointed as Additional Director on 06 Jun 2022. Rahul Khose was appointed as Additional Director on 06 Jun 2022. Lyrixo Pharma has 6 board changes on record in total.

The registered office of Lyrixo Pharma is at Sno 167168 Edenn Tower Pune – Bom Highway Rh No. 36, Maharashtra, India – 411027.

Lyrixo Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Lyrixo Pharma operates in the healthcare industry, in the human health activities segment.

No. Lyrixo Pharma is not listed on any stock exchange. It is an unlisted company.

Lyrixo Pharma can be reached at its registered office: Sno 167168 Edenn Tower Pune – Bom Highway Rh No. 36, Maharashtra, India – 411027.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available